Search Results - "Buus, S."

Dosimetric Impact of Needle Migration in Magnetic Resonance Imaging–Based High-Dose-Rate Brachytherapy by Lizondo Gisbert, M, Buus, S, Hokland, S.B, Rylander, S, Pedersen, E.M, Bentzen, L, Tanderup, K

Get full text

Definition of supertypes for HLA molecules using clustering of specificity matrices by Lund, Ole, Nielsen, Morten, Kesmir, Can, Petersen, Anders Gorm, Lundegaard, Claus, Worning, Peder, Sylvester-Hvid, Christina, Lamberth, Kasper, Røder, Gustav, Justesen, Sune, Buus, Søren, Brunak, Søren

“…Major histocompatibility complex (MHC) proteins are encoded by extremely polymorphic genes and play a crucial role in immunity. However, not all genetically…”
Get full text

Dwell time verification in brachytherapy based on time resolved in vivo dosimetry by Johansen, J.G., Kertzscher, G., Jørgensen, E.B., Rylander, S., Bentzen, L., Hokland, S.B., Søndergaard, C.S., With, A.K.M., Buus, S., Tanderup, K.

“…•Real-time in vivo dosimetry in prostate cancer brachytherapy.•Dwell times can be determined during patient treatment with in vivo dosimetry.•Afterloader…”
Get full text

EP-1255: Learning curve of MRI guided high dose rate brachytherapy for prostate cancer by Buus, S, Rylander, S, Hokland, S, Søndergaard, C.S, Pedersen, E.M, Tanderup, K, Bentzen, L

Get full text

SP-0365 Real-time MRI-based HDR prostate brachytherapy by Buus, S.

Get full text

EP-1931: Introduction of MRI guided HDR brachytherapy for high risk prostate cancer patients in a radiotherapy department by Buus, S, Rylander, S, Hokland, S, Søndergaard, C.S, Pedersen, E.M, Tanderup, K, Bentzen, L

Get full text

Identification of peptides from foot-and-mouth disease virus structural proteins bound by class I swine leukocyte antigen (SLA) alleles, SLA-10401 and SLA-20401 by Pedersen, L. E., Harndahl, M., Nielsen, M., Patch, J. R., Jungersen, G., Buus, S., Golde, W. T.

“…Summary Characterization of the peptide‐binding specificity of swine leukocyte antigen (SLA) class I and II molecules is critical to the understanding of…”
Get full text

Treatment of transplanted CT26 tumour with dendritic cell vaccine in combination with blockade of vascular endothelial growth factor receptor 2 and CTLA-4 by Pedersen, A.E., Buus, S., Claesson, M.H.

“…We investigated the anti CT26 tumour effect of dendritic cell based vaccination with the MuLV gp70 envelope protein-derived peptides AH1 and p320–333…”
Get full text

Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study by SVANE, Inge Marie, PEDERSEN, Anders E, JOHNSEN, Hans E, NIELSEN, Dorte, KAMBY, Claus, GAARSDAL, Eva, NIKOLAJSEN, Kirsten, BUUS, Søren, CLAESSON, Mogens H

“…Peptides derived from over-expressed p53 protein are presented by class I MHC molecules and may act as tumour-associated epitopes. Due to the diversity of p53…”
Get full text

Strategies to work with HLA data in human populations for histocompatibility, clinical transplantation, epidemiology and population genetics: HLA-NET methodological recommendations by Sanchez-Mazas, A., Vidan-Jeras, B., Nunes, J. M., Fischer, G., Little, A.-M., Bekmane, U., Buhler, S., Buus, S., Claas, F. H. J., Dormoy, A., Dubois, V., Eglite, E., Eliaou, J. F., Gonzalez-Galarza, F., Grubic, Z., Ivanova, M., Lie, B., Ligeiro, D., Lokki, M. L., da Silva, B. Martins, Martorell, J., Mendonça, D., Middleton, D., Voniatis, D. Papioannou, Papasteriades, C., Poli, F., Riccio, M. E., Vlachou, M. Spyropoulou, Sulcebe, G., Tonks, S., Nevessignsky, M. Toungouz, Vangenot, C., van Walraven, A.-M., Tiercy, J.-M.

“…Summary HLA‐NET (a European COST Action) aims at networking researchers working in bone marrow transplantation, epidemiology and population genetics to improve…”
Get full text

Identification of a Novel UTY-Encoded Minor Histocompatibility Antigen by Mortensen, B. K., Rasmussen, A. H., Larsen, M. E., Larsen, M. V., Lund, O., Braendstrup, P., Harndahl, M., Rasmussen, M., Buus, S., Stryhn, A., Vindeløv, L.

“…Minor histocompatibility antigens (mHags) encoded by the Y‐chromosome (H‐Y‐mHags) are known to play a pivotal role in allogeneic haematopoietic cell…”
Get full text

Using statistical decision theory to predict speech intelligibility. I. Model structure by Müsch, H, Buus, S

“…This article introduces a new model that predicts speech intelligibility based on statistical decision theory. This model, which we call the speech recognition…”
Get full text

High-affinity human leucocyte antigen class I binding variola-derived peptides induce CD4⁺ T cell responses more than 30 years post-vaccinia virus vaccination by Wang, M, Tang, S.T, Lund, O, Dziegiel, M.H, Buus, S, Claesson, M.H

“…Interferon-γ secreting T lymphocytes against pox virus-derived synthetic 9-mer peptides were tested by enzyme-linked immunospot in peripheral blood of…”
Get full text

Addition of TAT protein transduction domain and GrpE to human p53 provides soluble fusion proteins that can be transduced into dendritic cells and elicit p53-specific T-cell responses in HLA-A0201 transgenic mice by Justesen, S, Buus, S, Claesson, M.H, Pedersen, A.E

“…The protein p53 has been shown to be an efficient tumour antigen in both murine and human cancer vaccine studies and cancer vaccines targeting p53 based on…”
Get full text

MHC-I-restricted epitopes conserved among variola and other related orthopoxviruses are recognized by T cells 30 years after vaccination by Tang, S. T, Wang, M, Lamberth, K, Harndahl, M, Dziegiel, M. H, Claesson, M. H, Buus, S, Lund, O

“…It is many years since the general population has been vaccinated against smallpox virus. Here, we report that human leukocyte antigen (HLA) class I restricted…”
Get full text

Dendritic Cells Engineered to Express Defined Allo-HLA Peptide Complexes Induce Antigen-specific Cytotoxic T Cells Efficiently Killing Tumour Cells by Stronen, E, Abrahamsen, I.W, Gaudernack, G, Wälchli, S, Munthe, E, Buus, S, Johansen, F.-E, Lund-Johansen, F, Olweus, J

“…Most tumour-associated antigens (TAA) are non-mutated self-antigens. The peripheral T cell repertoire is devoid of high-avidity TAA-specific cytotoxic T…”
Get full text

HIV control through a single nucleotide on the HLA-I locus by Kløverpris, H, Harndahl, M, Carlson, J, Leslie, A, van der Stok, M, Huang, G, Chen, F, Riddell, L, Steyn, D, Goedhals, D, van Vuuren, C, Frater, J, Walker, B, Ndung'u', T, Buus, S, Goulder, P

“…Doc number: O47…”
Get full text

Phenotypic and Functional Characterization of Clinical Grade Dendritic Cells Generated from Patients with Advanced Breast Cancer for Therapeutic Vaccination by Pedersen, A. E., Thorn, M., Gad, M., Walter, M. R., Johnsen, H. E., Gaarsdal, E., Nikolajsen, K., Buus, S., Claesson, M. H., Svane, I. M.

“…Dendritic cells (DC) are promising candidates for cancer immunotherapy. However, it is not known whether in vitro‐generated monocyte‐derived DC from cancer…”
Get full text

P16-23. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance by Tenzer, S, Wee, E, Burgevin, A, Stewart-Jones, G, Friis, L, Lamberth, K, Chang, C, Harndahl, M, Weimershaus, M, Gerstoft, J, Akkad, N, Klenerman, P, Fugger, L, Jones, EY, McMichael, AJ, Buus, S, Schild, H, van Endert, P, Iversen, AK

Get full text

Modified Human Beta 2‐Microglobulin (desLys58) Displays Decreased Affinity for the Heavy Chain of MHC Class I and Induces Nitric Oxide Production and Apoptosis by Wang, M., Harhaji, L., Lamberth, K., Harndahl, M., Buus, S., Heegaard, N. H. H., Claesson, M. H., Nissen, M. H.

“…Beta2‐microglobulin (β2m) is the light chain of major histocompatibility complex class I (MHC‐I) molecules, and is a prerequisite for the binding of peptides…”
Get full text